Suspected immune-mediated myositis in horses.
Abstract: Although immune-mediated myositis (IMM) is commonly reported in other species, this condition is poorly described in horses. Objective: IMM occurs in horses. Methods: Thirty-seven horses with suspected IMM were included in the study. Methods: The database of the Neuromuscular Diagnostic Laboratory was reviewed to identify 37 horses with muscle biopsies characterized by lymphocytic infiltrates. A retrospective standardized questionnaire regarding clinical signs and response to treatment was answered by horse owners. Results: Horses with suspected IMM were predominantly of Quarter Horse bloodlines (33/37 horses) and primarily either or =17 years of age. Clinical signs included rapid atrophy, particularly of the epaxial and gluteal muscles, depression, and stiffness. Creatine kinase (CK) activity (mean 9746; range 260-139,183 U/L: reference range 119-287 U/L) and aspartate transaminase (AST) activity (mean 2880; range 350-9009 U/L: reference range 138-409 U/L) were high. Exposure to horses with infectious respiratory disease occurred in 39% (9/23) of horses before clinical signs and 47% (9/19) had recurrence of atrophy. Variation in dosage and time elapsed before administration of corticosteroids confounded assessment of treatment efficacy. Macrophages and CD4+ T lymphocytes were the prominent mononuclear cellular infiltrates with lesser numbers of CD8+ cells and small clusters of B lymphocytes in some samples. Myofibers did not stain for equine immunoglobulin G (IgG). Conclusions: IMM appears to be a distinct cause of rapid muscle atrophy, particularly in Quarter Horses that may be amenable to treatment with corticosteroids. Diagnosis is best achieved by identifying lymphocytic infiltrates in atrophied muscles.
Publication Date: 2007-06-08 PubMed ID: 17552457DOI: 10.1892/0891-6640(2007)21[495:simih]2.0.co;2Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research investigates the occurrence of immune-mediated myositis (IMM), a condition typically characterized by rapid muscle atrophy and inflammation, in horses. The evidence points to this condition being a common cause of muscular issues in horses, particularly those of Quarter Horse bloodlines, with possible treatment methods identified.
Study Design and Methods
- The researchers reviewed the Neuromuscular Diagnostic Laboratory database and identified 37 horses with muscle biopsies marked by lymphocytic infiltrates, an indicator of inflammation and potential IMM.
- A standard retrospective questionnaire was used to gather information about the clinical signs observed in these horses and their responses to treatments applied. This questionnaire was filled out by the horse owners.
- The majority of the horses with suspected IMM were Quarter Horses and were either less than or equal to 8 years old or more than or equal to 17 years old.
- Typical clinical signs included quick muscle loss, particularly in the epaxial and gluteal muscles, along with indications of depression and stiffness.
- Horses showed significantly high Creatine kinase (CK) activity and aspartate transaminase (AST) activity, both of which are indicators of muscle damage.
- The questionnaires revealed that exposure to horses with infectious respiratory diseases occurred in 39% of the horses prior to the onset of IMM symptoms.
- It was observed that in 47% of the cases, there was a recurrence of muscle atrophy.
- On examining the muscle biopsies, increased numbers of Macrohpages and CD4+ T lymphocytes were found. Lesser numbers of CD8+ cells and small clusters of B lymphocytes were also present.
- Assessment of treatment efficacy was challenging due to variations in corticosteroid dosage and timing of administration.
- However, the presence of lymphocytic infiltrates found in atrophied muscles is a strong indicator of IMM, assisting in diagnosis.
- The study concludes that IMM seems to be a distinct cause of rapid muscle atrophy, especially in Quarter Horses.
- Although the research did not provide definitive conclusions on treatment, the use of corticosteroids was seen as potentially feasible treatment method.
Study Findings
Treatment Effectiveness and Conclusions
Cite This Article
APA
Lewis SS, Valberg SJ, Nielsen IL.
(2007).
Suspected immune-mediated myositis in horses.
J Vet Intern Med, 21(3), 495-503.
https://doi.org/10.1892/0891-6640(2007)21[495:simih]2.0.co;2 Publication
Researcher Affiliations
- Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, St. Paul, MN, USA.
MeSH Terms
- Adrenal Cortex Hormones / therapeutic use
- Animals
- Biopsy / veterinary
- Female
- Horse Diseases / drug therapy
- Horse Diseases / immunology
- Horse Diseases / pathology
- Horses
- Immunohistochemistry / veterinary
- Lymphocytes / immunology
- Male
- Muscle, Skeletal / immunology
- Muscle, Skeletal / pathology
- Myositis / drug therapy
- Myositis / immunology
- Myositis / pathology
- Myositis / veterinary
- Prognosis
- Surveys and Questionnaires
- Treatment Outcome
Citations
This article has been cited 10 times.- Valberg SJ, Schultz AE, Finno CJ, Bellone RR, Hughes SS. Prevalence of clinical signs and factors impacting expression of myosin heavy chain myopathy in Quarter Horse-related breeds with the MYH1(E321G) mutation. J Vet Intern Med 2022 May;36(3):1152-1159.
- Ochala J, Finno CJ, Valberg SJ. Myofibre Hyper-Contractility in Horses Expressing the Myosin Heavy Chain Myopathy Mutation, MYH1(E321G). Cells 2021 Dec 6;10(12).
- Veronesi F, Di Palma S, Gabrielli S, Morganti G, Milardi GL, Middleton B, Lepri E. Sarcocystis gigantea infection associated with granulomatous eosinophilic myositis in a horse. J Vet Diagn Invest 2020 Jul;32(4):611-615.
- Gianino GM, Valberg SJ, Perumbakkam S, Henry ML, Gardner K, Penedo C, Finno CJ. Prevalence of the E321G MYH1 variant for immune-mediated myositis and nonexertional rhabdomyolysis in performance subgroups of American Quarter Horses. J Vet Intern Med 2019 Mar;33(2):897-901.
- Valberg SJ, Henry ML, Perumbakkam S, Gardner KL, Finno CJ. An E321G MYH1 mutation is strongly associated with nonexertional rhabdomyolysis in Quarter Horses. J Vet Intern Med 2018 Sep;32(5):1718-1725.
- Finno CJ, Gianino G, Perumbakkam S, Williams ZJ, Bordbari MH, Gardner KL, Burns E, Peng S, Durward-Akhurst SA, Valberg SJ. A missense mutation in MYH1 is associated with susceptibility to immune-mediated myositis in Quarter Horses. Skelet Muscle 2018 Mar 6;8(1):7.
- Boyle AG, Timoney JF, Newton JR, Hines MT, Waller AS, Buchanan BR. Streptococcus equi Infections in Horses: Guidelines for Treatment, Control, and Prevention of Strangles-Revised Consensus Statement. J Vet Intern Med 2018 Mar;32(2):633-647.
- Hunyadi L, Sundman EA, Kass PH, Williams DC, Aleman M. Clinical Implications and Hospital Outcome of Immune-Mediated Myositis in Horses. J Vet Intern Med 2017 Jan;31(1):170-175.
- Durward-Akhurst SA, Finno CJ, Barnes N, Shivers J, Guo LT, Shelton GD, Valberg SJ. Major Histocompatibility Complex I and II Expression and Lymphocytic Subtypes in Muscle of Horses with Immune-Mediated Myositis. J Vet Intern Med 2016 Jul;30(4):1313-21.
- Durward-Akhurst SA, Valberg SJ. Myosin Heavy Chain Myopathy and Immune-Mediated Muscle Disorders. Vet Clin North Am Equine Pract 2025 Apr;41(1):61-75.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists